| P50 | author | Zdenka Kuncic | Q51348575 |
| | Yaser Hadi Gholami | Q85659132 |
| P2093 | author name string | Richard Maschmeyer | |
| P2860 | cites work | Geant4 | Q1412851 |
| | Targeted radionuclide therapies for pancreatic cancer | Q26801364 |
| | Antibody-targeted radiation cancer therapy | Q28264580 |
| | Radiotherapy enhancement with gold nanoparticles | Q28288052 |
| | Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization. | Q30366774 |
| | Interaction of gold nanoparticles with common human blood proteins. | Q30383615 |
| | Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors | Q30930526 |
| | Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside | Q31065446 |
| | GATE: a simulation toolkit for PET and SPECT. | Q31130081 |
| | Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review | Q33503551 |
| | Chelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticles | Q33691661 |
| | Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle. | Q33841759 |
| | First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases | Q34426777 |
| | Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray". | Q35880923 |
| | In silico nanodosimetry: new insights into nontargeted biological responses to radiation | Q36021668 |
| | Cancer radioimmunotherapy with alpha-emitting nuclides | Q36102652 |
| | The High Radiosensitizing Efficiency of a Trace of Gadolinium-Based Nanoparticles in Tumors | Q37093101 |
| | Targeted radionuclide therapy | Q37148148 |
| | Magnetic nanoparticles in MR imaging and drug delivery. | Q37192908 |
| | Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy | Q37194020 |
| | Risks to normal tissues from radionuclide therapy | Q37228873 |
| | Therapeutic radionuclides: biophysical and radiobiologic principles | Q37228877 |
| | Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. | Q38212196 |
| | Radionanomedicine: widened perspectives of molecular theragnosis | Q38342089 |
| | Study on dependence of dose enhancement on cluster morphology of gold nanoparticles in radiation therapy using a body-centred cubic model | Q38612776 |
| | Track structure modeling in liquid water: A review of the Geant4-DNA very low energy extension of the Geant4 Monte Carlo simulation toolkit | Q38664997 |
| | Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles | Q38998501 |
| | The in vivo radiosensitizing effect of gold nanoparticles based MRI contrast agents. | Q39012715 |
| | Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles | Q39119168 |
| | Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy | Q39472564 |
| | Fundamental uncertainty equations for nuclear dating applied to the 140Ba-140La and 227Th-223Ra chronometers. | Q39652382 |
| | Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. | Q39676291 |
| | Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis. | Q40213018 |
| | Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides. | Q40272394 |
| | The use of gold nanoparticles to enhance radiotherapy in mice | Q40499366 |
| | Low-dose-rate irradiation by 131I versus high-dose-rate external-beam irradiation in the rat pancreatic tumor cell line CA20948. | Q40530008 |
| | Dose enhancement effects to the nucleus and mitochondria from gold nanoparticles in the cytosol | Q41468679 |
| | Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment | Q41475179 |
| | Determinants of the antitumor effect of radiolabeled monoclonal antibodies. | Q41724892 |
| | 213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer. | Q41856358 |
| | On the equivalent dose for Auger electron emitters. | Q42150699 |
| | Superparamagnetic iron oxide nanoparticles as novel X-ray enhancer for low-dose radiation therapy. | Q42802753 |
| | In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus | Q47557035 |
| | Technical Note: Improvements in geant4 energy-loss model and the effect on low-energy electron transport in liquid water | Q47635732 |
| | Toward Personalized Dosimetry with 32P Microparticle Therapy for Advanced Pancreatic Cancer. | Q47731805 |
| | Dosimetric consequences of gold nanoparticle clustering during photon irradiation. | Q47849946 |
| | Heat-induced radiolabeling and fluorescence labeling of Feraheme nanoparticles for PET/SPECT imaging and flow cytometry | Q48166193 |
| | Monte Carlo modeling and optimization of contrast-enhanced radiotherapy of brain tumors | Q49142588 |
| | Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings | Q49389681 |
| | Nanoparticle radio-enhancement: principles, progress and application to cancer treatment. | Q50070213 |
| | Physician/patient-driven risk assignment in radiation oncology: reality or fancy? | Q52262875 |
| | Complication probability as assessed from dose-volume histograms. | Q52682588 |
| | Global comparison of targeted alpha vs targeted beta therapy for cancer: In vitro, in vivo and clinical trials. | Q52684622 |
| | Geant4-DNA track-structure simulations for gold nanoparticles: The importance of electron discrete models in nanometer volumes. | Q52685382 |
| | Feasibility study of Fe3O4/TaOx nanoparticles as a radiosensitizer for proton therapy. | Q53068805 |
| | Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results. | Q55470691 |
| | Copper radiopharmaceuticals for theranostic applications | Q57117803 |
| | Radioactive Transition Metals for Imaging and Therapy | Q57288103 |
| | Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging | Q58740856 |
| | Comparison of radiobiological parameters for Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro | Q58769730 |
| | Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy | Q59382376 |
| | Geant4-DNA example applications for track structure simulations in liquid water: A report from the Geant4-DNA Project | Q61509246 |
| | Investigation of track structure and condensed history physics models for applications in radiation dosimetry on a micro and nano scale in Geant4 | Q61509255 |
| | An implementation of discrete electron transport models for gold in the Geant4 simulation toolkit | Q61509294 |
| | Influence of track structure and condensed history physics models of Geant4 to nanoscale electron transport in liquid water | Q61509945 |
| | Inelastic mean free path of low-energy electrons in condensed media: beyond the standard models | Q61509950 |
| | Nuclear nanomedicine using Si nanoparticles as safe and effective carriers of Re radionuclide for cancer therapy | Q61796135 |
| | Irradiation of gold nanoparticles by x-rays: Monte Carlo simulation of dose enhancements and the spatial properties of the secondary electrons production | Q61902152 |
| | Geant4-DNA example applications for track structure simulations in liquid water: A report from the Geant4-DNA Project | Q64124215 |
| | Physical and biological interface dose effects in tissue due to X-ray-induced release of secondary radiation from metallic gold surfaces | Q74743840 |
| | Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles | Q82272241 |
| | Stochastic simulation of radium-223 dichloride therapy at the sub-cellular level | Q85659136 |
| | Nanoparticles as multimodal photon transducers of ionizing radiation | Q88182748 |
| | Evaluation of the microscopic dose enhancement for nanoparticle-enhanced Auger therapy | Q88509905 |
| | [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study | Q88645082 |
| | [177Lu]PSMA-617 radionuclide therapy shows promise | Q88778600 |
| | AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine | Q91504154 |
| | Electron track structure simulations in a gold nanoparticle using Geant4-DNA | Q92913822 |
| P433 | issue | 1 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 14346 | |
| P577 | publication date | 2019-10-04 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Radio-enhancement effects by radiolabeled nanoparticles | |
| P478 | volume | 9 | |